The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps?
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Prepulse inhibition (PPI) of startle is an operational measure of the pre-attentive filtering process known as sensorimotor gating. Originally identified in patients with schizophrenia, PPI deficits have been observed in multiple but not all psychiatric disorders. Thus, as with most signs and symptoms of psychiatric disorders, deficits in PPI cut across diagnostic categories. It remains unclear whether the diversity of disorders exhibiting deficient PPI bespeaks diagnostic overlaps or comorbidities. Given the recent focus on treatments for cognitive deficits of schizophrenia independently of treating psychosis, the relationship of PPI deficits to cognitive deficits becomes of interest. Although PPI cannot be considered to be a cognitive process per se, abnormalities in pre-attentive information processing may be predictive of or lead to complex cognitive deficits. Animal models of PPI deficits produced by dopamine agonists reliably predict existing antipsychotics. Nevertheless, since neither PPI nor cognitive deficits in schizophrenia are ameliorated by standard antipsychotics, current research is exploring the predictive value of non-dopaminergic PPI models in identifying treatments for gating disturbances independently of their relevance to specific disorders. Both PPI and cognitive deficits in schizophrenia patients are not reversed by first generation antipsychotics but may be attenuated by clozapine. Similarly, effects of glutamate antagonists on symptoms in patients and PPI in animals appear to be reduced by clozapine. Hence, treatment-induced reversals of deficits in PPI produced by glutamate antagonists may provide animal, and human, models to aid in the discovery of treatments of cognitive deficits in patients already treated with existing antipsychotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pallidal, thalamic, and motor cortex activity is also associated with checking symptoms in OCD(89).”
From Functional disruption of cerebello-thalamo-cortical networks in obsessive-compulsive disorder (2020) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
Self-citationGeyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Self-citationLongitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
Green, M. F., Kern, R. S., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.009 · Cited by 1,422 · cited 2×
“Third, a consensus process was used to develop recommendations for the appropriate cognitive tests to be used in clinical assessments of potential cognitive enhancers (Green et al., 2004b).”
BackgroundMethodSensorimotor Gating and Schizophrenia: Human and Animal Model Studies
Braff, D. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810140081011 · Cited by 1,309
Self-citationIdentification of separable cognitive factors in schizophrenia
Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.007 · Cited by 1,304 · cited 1×
“ucla.edu). First, the Neurocognition Committee identified the primary domains of cognitive deficits that characterize patients with schizophrenia: working memory; attention/vigilance; verbal learning and memory; visual learning and memory; speed of processing; reasoning and problem-solving; and social cognition ( Nuec…”
BackgroundPrestimulus Effects on Human Startle Reflex in Normals and Schizophrenics
Braff, D., Stone, C., Callaway, E., Geyer, M., Glick, I., & Bali, L. (1978) · Psychophysiology · doi:10.1111/j.1469-8986.1978.tb01390.x · Cited by 1,170
Self-citationThe more or less startling effects of weak prestimulation
Graham, F. K. (1975) · Psychophysiology · doi:10.1111/j.1469-8986.1975.tb01284.x · Cited by 1,119
Swerdlow, N., Geyer, M., & Braff, D. (2001) · Psychopharmacology · doi:10.1007/s002130100799 · Cited by 1,050
Self-citationThe Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia
Meltzer, H. Y., & McGurk, S. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033376 · Cited by 1,020
Neuropsychopharmacology: The Fifth Generation of Progress
SAGDUYU, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,019
Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., Fenton, W. S., Frese, F., Goldberg, T. E., Heaton, R. K., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.023 · Cited by 919 · cited 3×
“Third, a consensus process was used to develop recommendations for the appropriate cognitive tests to be used in clinical assessments of potential cognitive enhancers (Green et al., 2004b).”
BackgroundMethodAssessing the Validity of an Animal Model of Deficient Sensorimotor Gating in Schizophrenic Patients
Swerdlow, N. R. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020063007 · Cited by 703
Self-citationNMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers
Malhotra, A. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00137-3 · Cited by 680
Malhotra, M. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00036-5 · Cited by 680
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544 · cited 2×
“In contrast to D2 antagonist effects, manipulations of dopamine D 1 receptors was considered one of the most promising possible targets for pro-cognitive agents in schizophrenia by the MATRICS Neuropharmacology group ( Goldman-Rakic et al., 2004 ).”
BackgroundStartle response models of sensorimotor gating and habituation deficits in schizophrenia
Geyer, M. A., Swerdlow, N. R., Mansbach, R. S., & Braff, D. L. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90241-q · Cited by 454
Self-citationBrain anatomy and sensorimotor gating in Asperger's syndrome
McAlonan, G. M. (2002) · Brain · doi:10.1093/brain/awf150 · Cited by 447
Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi020 · Cited by 438
Marder, S. R., & Fenton, W. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.010 · Cited by 421
Startle Habituation and Sensorimotor Gating in Schizophrenia and Related Animal Models
Geyer, M. A., & Braff, D. L. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.4.643 · Cited by 413
Self-citationA systems model of altered consciousness: integrating natural and drug-induced psychoses
Vollenweider, F. X., & Geyer, M. A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00646-3 · Cited by 343
Self-citationAlpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 342
Mouse genetic models for prepulse inhibition: an early review
Geyer, M. A., McIlwain, K. L., & Paylor, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001159 · Cited by 285
Self-citationWhat Are the Right Targets for Psychopharmacology?
Hyman, S. E., & Fenton, W. S. (2003) · Science · doi:10.1126/science.1077141 · Cited by 283
Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
Frankland, P. W., Wang, Y., Rosner, B., Shimizu, T., Balleine, B. W., Dykens, E. M., Ornitz, E. M., & Silva, A. J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001432 · Cited by 275 · cited 2×
“…deficits in PPI have also been identified in children with 22q deletion syndrome (Sobin et al., 2005), young persons with Fragile X syndrome (Frankland et al., 2004), and adults with Asperger's syndrome (McAlonan et al., 2002), seizure disorder (Pouretemad et al., 1998), or Lewy body…”
BackgroundRalph, R. J., Paulus, M. P., Fumagalli, F., Caron, M. G., & Geyer, M. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-00305.2001 · Cited by 271 · cited 1×
“Similarly, the disruptions of PPI observed in dopamine transporter knockout mice, likely mediated indirectly via the increased synaptic levels of dopamine, are reversed by D2 and not D1 receptor antagonists (Ralph et al., 2001).”
BackgroundSelf-citationSensorimotor gating deficits in bipolar disorder patients with acute psychotic mania
Perry, W., Minassian, A., Feifel, D., & Braff, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01184-2 · Cited by 258
Normalization of Information Processing Deficits in Schizophrenia With Clozapine
Kumari, V., Soni, W., & Sharma, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1046 · Cited by 243
Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia
Ludewig, K., Geyer, M. A., & Vollenweider, F. X. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01925-x · Cited by 240
Self-citationAnimal behavior models of the mechanisms underlying antipsychotic atypicality
Geyer, M. A., & Ellenbroek, B. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.003 · Cited by 238
Self-citationPerry, W., Geyer, M. A., & Braff, D. L. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.3.277 · Cited by 236
Self-citationClozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine
Malhotra, A. K., Adler, C. M., Kennison, S. D., Elman, I., Pickar, D., & Breier, A. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00546-x · Cited by 200
Impaired Prepulse Inhibition of Acoustic Startle in Obsessive-Compulsive Disorder
Hoenig, K., Hochrein, A., Quednow, B. B., Maier, W., & Wagner, M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.040 · Cited by 191
Ralph, R. J., Varty, G. B., Kelly, M. A., Wang, Y.-M., Caron, M. G., Rubinstein, M., Grandy, D. K., Low, M. J., & Geyer, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04627.1999 · Cited by 174 · cited 2×
“Extensive studies with both selective antagonists and receptor subtype-specific knockout mice have demonstrated that the effects of amphetamine on PPI are attributable to actions at the D2 subtype of the D2-family of dopamine receptors, and not to D1, D3, or D4 receptors ( Ralph et al., 1999; Ralph-Williams et al., 20…”
BackgroundSelf-citationLe Pen, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00383-9 · Cited by 173
Kumari, V., & Sharma, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1099-x · Cited by 170
Bakshi, V. P., & Geyer, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08394.1998 · Cited by 167
Self-citationSwerdlow, N. R., Martinez, Z. A., Hanlon, F. M., Platten, A., Farid, M., Auerbach, P., Braff, D. L., & Geyer, M. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04325.2000 · Cited by 162
Self-citationAlternative phenotypes for the complex genetics of schizophrenia
Freedman, R., Adler, L. E., & Leonard, S. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00321-7 · Cited by 158
Prepulse inhibition deficits in patients with panic disorder
Ludewig, S., Ludewig, K., Geyer, M. A., Hell, D., & Vollenweider, F. X. (2002) · Depression and Anxiety · doi:10.1002/da.10026 · Cited by 157
Self-citationPreliminary evidence of an association between sensorimotor gating and distractibility in psychosis
(1996) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.8.1.60 · Cited by 130
Information-processing deficits and cognitive dysfunction in panic disorder
Ludewig, S., Geyer, M. A., Ramseier, M., Vollenweider, F. X., Rechsteiner, E., & Cattapan-Ludewig, K. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0506 · Cited by 125
Self-citationRalph, R. J., & Caine, S. B. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074468 · Cited by 111
Lower Prepulse Inhibition in Children With the 22q11 Deletion Syndrome
Sobin, C., Kiley-Brabeck, K., & Karayiorgou, M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1090 · Cited by 111
Ralph-Williams, R. J., Lehmann-Masten, V., Otero-Corchon, V., Low, M. J., & Geyer, M. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09604.2002 · Cited by 110
Self-citationPredicting Drug Efficacy for Cognitive Deficits in Schizophrenia
Hagan, J. J. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi058 · Cited by 110
Dopamine D1 Rather than D2 Receptor Agonists Disrupt Prepulse Inhibition of Startle in Mice
Ralph-Williams, R. J., Lehmann-Masten, V., & Geyer, M. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300017 · Cited by 105 · cited 2×
“Nevertheless, in contrast to rats, D1 agonists are much more effective than D2 agonists in disrupting PPI in mice (Ralph-Williams et al., 2002; 2003; Ralph and Caine, 2005).”
BackgroundSelf-citationFloresco, S. B. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi041 · Cited by 95
Self-citationHawk, L. W., Yartz, A. R., Pelham, W. E., & Lock, T. M. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1235-7 · Cited by 89 · cited 2×
“Similarly, boys diagnosed with attentiondeficit hyperactivity disorder (ADHD) exhibit deficits in the attentional modulation of PPI, although they appear to be normal in the typical passive PPI paradigm used in most other studies (Hawk et al., 2003).”
BackgroundResultMeincke, U., Mörth, D., Voß, T., Thelen, B., Geyer, M. A., & Gouzoulis‐Mayfrank, E. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0523-0 · Cited by 88
Self-citationReversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys
Linn, G. S., Negi, S., Gerum, S. V., & Javitt, D. C. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1533-8 · Cited by 84
Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice
Brody, S. A., Conquet, F., & Geyer, M. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1635-3 · Cited by 71
Self-citationPerriol, M.-P. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.035022 · Cited by 71
Long-term evaluation of isolation-rearing induced prepulse inhibition deficits in rats: an update
Cilia, J., Hatcher, P. D., Reavill, C., & Jones, D. N. C. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2139-5 · Cited by 68
Swerdlow, N. R., Eastvold, A. D., Karban, B., Ploum, Y., Stephany, N., Geyer, M. A., Cadenhead, K. S., & Auerbach, P. P. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1040-3 · Cited by 65
Self-citationPrepulse inhibition in patients with non-psychotic major depressive disorder
Perry, W., Minassian, A., & Feifel, D. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00157-5 · Cited by 60
Geyer, M., & Tamminga, C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1846-2 · Cited by 57
Self-citationPrepulse inhibition in patients with Alzheimer’s disease
Hejl, A., Glenthoj, B. Y., Mackeprang, T., Hemmingsen, R., & Waldemar, G. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.005 · Cited by 57
Abduljawad, K. A. J., Langley, R. W., Bradshaw, C. M., & Szabadi, E. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300101 · Cited by 55
Quednow, B. B., K�hn, K.-U., Stelzenmueller, R., Hoenig, K., Maier, W., & Wagner, M. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1842-6 · Cited by 54
Developmental markers of psychiatric disorders as identified by sensorimotor gating
Powell, S. B., & Geyer, M. A. (2002) · Neurotoxicity Research · doi:10.1080/10298420290030578 · Cited by 47
Self-citationImpaired sensorimotor gating in patients with non-epileptic seizures
Pouretemad, H. R., Thompson, P. J., & Fenwick, P. B. C. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(98)00014-x · Cited by 41
Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective
Fenton, W. S., Stover, E. L., & Insel, T. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1564-1 · Cited by 37
New Approaches to Measurement and Treatment Research to Improve Cognition in Schizophrenia
Geyer, M. A., & HEINSSEN, R. K. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi057 · Cited by 36
Self-citationAn investigation of prepulse inhibition in pediatric bipolar disorder
Rich, B. A., Vinton, D. T., Grillon, C., Bhangoo, R. K., & Leibenluft, E. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00183.x · Cited by 33
Swerdlow, N. R., Krupin, A. S., Bongiovanni, M. J., Shoemaker, J. M., Goins, J., & Hammer, R. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300877 · Cited by 30
No prepulse inhibition deficits in patients with unipolar depression
Ludewig, S., & Ludewig, K. (2003) · Depression and Anxiety · doi:10.1002/da.10109 · Cited by 23
Impaired sensorimotor gating in patients with non-epileptic seizures
Pouretemad, H. R., Thompson, P. J., & Fenwick, P. B. C. (1998) · Seizure · doi:10.1016/s1059-1311(98)90026-7 · Cited by 5
Research works printed but not linked: 1
- Geyer MA and A Markou (2002) The role of preclinical models in the development of psychotropic drugs, In:Neuropsychopharm-acology: The Fifth Generation of Progress (Davis KL, D Charney, J.T. Coyle and C Nemeroff, Eds.) (Lippincott Williams and Wilkins:Philadelphia, PA), pp 445–455.
Cited by
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 409
Ramonet, D., Daher, J. P. L., Lin, B. M., Stafa, K., Kim, J., Banerjee, R., Westerlund, M., Pletnikova, O., Glauser, L., Yang, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018568 · Cited by 405
“We also assessed prepulse inhibition of the acoustic startle reflex, a measure of sensorimotor gating that can be modulated in part by dopaminergic neurotransmission [39].”
MethodEpidemiology-driven neurodevelopmental animal models of schizophrenia
Meyer, U., & Feldon, J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.018 · Cited by 372
Schizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology
KESHAVAN, M., TANDON, R., BOUTROS, N., & NASRALLAH, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.020 · Cited by 347
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328
“…Cryan et al, 2002; Millan and Brocco, 2003; Matthews and Robbins, 2003; Willner, 2005; Einat and Manji, 2006; Steckler et al, 2008; Gotz et al, 2004; Janus et al, 2007; Geyer 2006a; Ellenbroek and Cools, 2000; Carter et al, 2008; Enomoto et al, 2007; McGowan et al, 2006; Gotz and Ittner, 2008).”
InfluentialSelf-citation
Metadata
- Authors
- Geyer, M. A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Geyer, Mark A.
- ORCID
- Geyer, Mark A.
- Venue
- Neurotoxicity Research
- Published
- 2006-09
- Volume
- 10
- Issue
- 3-4
- Pages
- 211-220
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- PMC
- PMC2667105
- OpenAlex
- W1988299084
- Cited by
- 159
- References
- 70
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 9 · 2014: 11 · 2013: 8 · 2012: 10
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurotoxicity Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH42228, R37MH042228, MH61326, R01MH071916, R01MH042228, R01MH061326, MH071916)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- prepulse inhibition, sensorimotor gating, schizophrenia, cognitive impairment, comorbidities, diagnostic overlap, clozapine, antipsychotic drugs, glutamate receptor antagonists, dopamine agonists, animal models
- MeSH terms
- Animals, Dopamine, Humans, Movement Disorders, Schizophrenia, Schizophrenic Psychology, Sensation Disorders, Reflex, Startle, Drug Design, Receptors, N-Methyl-D-Aspartate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.